Robert Mott
- Ophthalmology top 1%
- Retinal Diseases and Treatments 11
- Glaucoma and retinal disorders 3
- Clinical Biochemistry top 2%
- Advanced Glycation End Products research 3
- Nephrology top 5%
- Chronic Kidney Disease and Diabetes 2
- Neurology top 10%
- Physiology top 10%
-
- Retinal Imaging and Analysis 2
- Retinopathy of Prematurity Studies 2
-
- Retinal Development and Disorders 2
- Wnt/β-catenin signaling in development and cancer 2
Robert Mott
14 papers receiving 1.0k citations
Peers
Comparison fields: 5 of 81
- Ophthalmology 457
- Clinical Biochemistry 162
- Nephrology 88
- Neurology 93
- Physiology 39
Countries citing papers authored by Robert Mott
This map shows the geographic impact of Robert Mott's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Robert Mott with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Robert Mott more than expected).
Fields of papers citing papers by Robert Mott
This network shows the impact of papers produced by Robert Mott. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Robert Mott. The network helps show where Robert Mott may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Robert Mott, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2012 | 55 | |
| 2 | 2012 | 69 | |
| 3 | 2012 | 141 | |
| 4 | Mechanisms for the Therapeutic Effect of Fenofibrate on Diabetic Retinopathy in Type 1 Diabetes Models | 2011 | 1 |
| 5 | 2011 | 12 | |
| 6 | Therapeutic Effect of Fenofibrate on Age Related Macular Degeneration | 2011 | 1 |
| 7 | 2009 | 133 | |
| 8 | 2009 | 61 | |
| 9 | 2008 | 77 | |
| 10 | 2007 | 9 | |
| 11 | 2006 | 56 | |
| 12 | 2006 | 82 | |
| 13 | 2005 | 253 | |
| 14 | 2005 | 74 |
About Robert Mott
Robert Mott is a scholar working on Ophthalmology, Clinical Biochemistry and Nephrology, having authored 14 papers that have together received 1.0k indexed citations. Recurring topics across this work include Retinal Diseases and Treatments (11 papers), Advanced Glycation End Products research (3 papers), Glaucoma and retinal disorders (3 papers), Retinal Imaging and Analysis (2 papers), Retinal Development and Disorders (2 papers), Wnt/β-catenin signaling in development and cancer (2 papers), Retinopathy of Prematurity Studies (2 papers) and Chronic Kidney Disease and Diabetes (2 papers). The work is most often cited by research in Ophthalmology (457 citations), Clinical Biochemistry (162 citations) and Nephrology (88 citations). Robert Mott has collaborated with scholars based in United States, France and China. Frequent co-authors include Jian‐xing Ma, Sarah X. Zhang, Joshua J. Wang, Guoquan Gao, Yang Hu, Ying Chen, Chunkui Shao, Timothy J. Lyons, Mingkai Lin and Kangmo Lu. Their work appears in journals such as Diabetes, Investigative Ophthalmology & Visual Science, Experimental Eye Research, Journal of the American Society of Nephrology and Journal of Molecular Endocrinology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.